Across TCGA pan-cancer cohorts, LINC02111 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC02111 data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC02111 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02111 expression acts as an unfavorable survival marker, although some lineages such as UCS and SARC show a favorable association.
HNSC, ACC, and UCS are the cancer types where LINC02111 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.